HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hypogammaglobulinemia in the early period after liver transplantation in children.

Abstract
Data, on the kinetic and serum levels of immunoglobulins in the immediate post-liver transplantation (LTx) period, are sparse with existing studies limited to adults or case reports of children. The aim of this study is to describe the phenomenon of hypogammaglobulinemia (HGG) in the immediate post-transplantation period among children undergoing LTx. A retrospective 10-yr chart review was conducted of all children who underwent LTx at a fourth-level pediatric medical center. Fifty-seven, of the 76 children who underwent LTx, were included in the study. Seventeen (29.8%) (mean age, 6.8 ± 5.2 yr) had HGG (11-IgG, 1-IgG+IgA, 1-IgG+IgM, 4-IgG+IgA+IgM), detected at 2 to 25 d after transplantation. Abdominal fluid was drained for 5 to 42 d; the amount drained until detection of HGG measured 27-668 mL/kg. HGG was associated with increased infection rate 0.9 episodes/patient vs. 0.17 episodes/patient (p < 0.01) in children without detected HGG. In conclusion, HGG is not rare in the immediate post-LTx period in children, and it may place patients at increased risk of infection. Further studies are needed to delineate the rate of occurrence, risk factors, and clinical implications of hypogammaglobulinemia in this patient population.
AuthorsYael Mozer-Glassberg, Raanan Shamir, Ran Steinberg, Gili Kadmon, Efrat Har-Lev, Eytan Mor, Rivka Shapiro, Tommy Schonfeld, Elhanan Nahum
JournalClinical transplantation (Clin Transplant) 2013 May-Jun Vol. 27 Issue 3 Pg. E289-94 ISSN: 1399-0012 [Electronic] Denmark
PMID23551332 (Publication Type: Journal Article)
Copyright© 2013 John Wiley & Sons A/S.
Topics
  • Adolescent
  • Adult
  • Agammaglobulinemia (diagnosis, etiology)
  • Child
  • Child, Preschool
  • Female
  • Follow-Up Studies
  • Humans
  • Infant
  • Liver Diseases (complications, surgery)
  • Liver Transplantation (adverse effects)
  • Male
  • Postoperative Complications
  • Prognosis
  • Retrospective Studies
  • Risk Factors
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: